WBR0902: Difference between revisions

Jump to navigation Jump to search
(Created page with "{{WBRQuestion |QuestionAuthor={{Rim}} |Prompt=A researcher is investigating the effects of two drugs A and B on blood pressure in rats. The graph below shows the maximal effe...")
 
No edit summary
Line 1: Line 1:
{{WBRQuestion
{{WBRQuestion
|QuestionAuthor={{Rim}}
|QuestionAuthor={{Rim}}
|ExamType=USMLE Step 1
|MainCategory=Pharmacology
|SubCategory=General Principles
|MainCategory=Pharmacology
|SubCategory=General Principles
|MainCategory=Pharmacology
|SubCategory=General Principles
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=General Principles
|MainCategory=Pharmacology
|SubCategory=General Principles
|MainCategory=Pharmacology
|SubCategory=General Principles
|MainCategory=Pharmacology
|SubCategory=General Principles
|MainCategory=Pharmacology
|MainCategory=Pharmacology
|SubCategory=General Principles
|Prompt=A researcher is investigating the effects of two drugs A and B on blood pressure in rats.  The graph below shows the maximal effect of A in decreasing blood pressure when administered alone or when administered in combination with B.  Which of the following combinations has an interaction similar to that of A and B?
|Prompt=A researcher is investigating the effects of two drugs A and B on blood pressure in rats.  The graph below shows the maximal effect of A in decreasing blood pressure when administered alone or when administered in combination with B.  Which of the following combinations has an interaction similar to that of A and B?
|Explanation=Efficacy is defined as the maximal effect a drug can produce. While a full agonist produces maximal effect, a partial agonist only leads to less effect when compared to a full agonist.  
|Explanation=Efficacy is defined as the maximal effect a drug can produce. While a full agonist produces maximal effect, a partial agonist only leads to less effect when compared to a full agonist.  
Line 6: Line 25:
According to the figure, when A is alone, a maximal effect is produced. However, when A and B are combined the curve is shifted downwards depicting decreased efficacy.  An increase in the concentration of A was not able to overcome the effect of B on the efficacy. Hence B is a non-competitive inhibitor.  Phenoxybenzamine is a noncompetitive inhibitor of norepinephrine.
According to the figure, when A is alone, a maximal effect is produced. However, when A and B are combined the curve is shifted downwards depicting decreased efficacy.  An increase in the concentration of A was not able to overcome the effect of B on the efficacy. Hence B is a non-competitive inhibitor.  Phenoxybenzamine is a noncompetitive inhibitor of norepinephrine.


Educational objective:  
Educational objective:
|AnswerA=[[Naloxone]] and [[morphine]]
|AnswerA=[[Naloxone]] and [[morphine]]
|AnswerAExp=Naloxone is a competitive antagonist of morphine. When a competitive antagonist is present, the potency of the agonist is altered and the curve of the effect of the agonist by increasing dose will be shifted towards the right.
|AnswerAExp=Naloxone is a competitive antagonist of morphine. When a competitive antagonist is present, the potency of the agonist is altered and the curve of the effect of the agonist by increasing dose will be shifted towards the right.

Revision as of 16:11, 4 December 2013

 
Author [[PageAuthor::Rim Halaby, M.D. [1]]]
Exam Type ExamType::USMLE Step 1
Main Category MainCategory::Pharmacology
Sub Category SubCategory::General Principles
Prompt [[Prompt::A researcher is investigating the effects of two drugs A and B on blood pressure in rats. The graph below shows the maximal effect of A in decreasing blood pressure when administered alone or when administered in combination with B. Which of the following combinations has an interaction similar to that of A and B?]]
Answer A [[AnswerA::Naloxone and morphine]]
Answer A Explanation AnswerAExp::Naloxone is a competitive antagonist of morphine. When a competitive antagonist is present, the potency of the agonist is altered and the curve of the effect of the agonist by increasing dose will be shifted towards the right.
Answer B [[AnswerB::Atropine and acetylcholine]]
Answer B Explanation AnswerBExp::Atropine is a competitive antagonist of acetylcholine. When a competitive antagonist is present, the potency of the agonist is altered and the curve of the effect of the agonist by increasing dose will be shifted towards the right.
Answer C [[AnswerC::Haloperidol and dopamine]]
Answer C Explanation AnswerCExp::haloperidol is a competitive antagonist of dopamine. When a competitive antagonist is present, the potency of the agonist is altered and the curve of the effect of the agonist by increasing dose will be shifted towards the right.
Answer D [[AnswerD::Ondansetron and serotonin]]
Answer D Explanation AnswerDExp::Serotonin is a competitive antagonist of ondansetron. When a competitive antagonist is present, the potency of the agonist is altered and the curve of the effect of the agonist by increasing dose will be shifted towards the right.
Answer E [[AnswerE::Noreprinephrine and phenoxybenzamine]]
Answer E Explanation AnswerEExp::Phenoxybenzamine is a noncompetitive inhibitor of norepinephrine. An increase in the concentration of norepinephrine is not able to overcome the effect of phenoxybenzamine .
Right Answer RightAnswer::E
Explanation [[Explanation::Efficacy is defined as the maximal effect a drug can produce. While a full agonist produces maximal effect, a partial agonist only leads to less effect when compared to a full agonist.

Potency is defined effect is produced for a given concentration of a drug. The lower the concentration of a substance to produce an effect, the higher the affinity of the substance to the receptor and hence the higher the potency. According to the figure, when A is alone, a maximal effect is produced. However, when A and B are combined the curve is shifted downwards depicting decreased efficacy. An increase in the concentration of A was not able to overcome the effect of B on the efficacy. Hence B is a non-competitive inhibitor. Phenoxybenzamine is a noncompetitive inhibitor of norepinephrine.

Educational objective:
Educational Objective:
References: ]]

Approved Approved::No
Keyword
Linked Question Linked::
Order in Linked Questions LinkedOrder::